Spectrophores as one-dimensional descriptors calculated from three-dimensional atomic properties: applications ranging from scaffold hopping to multi-target virtual screening
暂无分享,去创建一个
Rafaela Gladysz | Koen Augustyns | Hans De Winter | Fabio Mendes Dos Santos | Wilfried Langenaeker | Gert Thijs | G. Thijs | K. Augustyns | Rafaela Gladysz | H. De Winter | W. Langenaeker | F. M. dos Santos
[1] Paul D Lyne,et al. Structure-based virtual screening: an overview. , 2002, Drug discovery today.
[2] Rafael Gozalbes,et al. Small molecule databases and chemical descriptors useful in chemoinformatics: an overview. , 2011, Combinatorial chemistry & high throughput screening.
[3] David A. Cosgrove,et al. Lead Hopping Using SVM and 3D Pharmacophore Fingerprints , 2005, J. Chem. Inf. Model..
[4] G. Maggiora,et al. Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.
[5] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[6] Kam Y. J. Zhang,et al. Pharmacophore modeling: advances, limitations, and current utility in drug discovery , 2014 .
[7] Hugo Kubinyi,et al. Similarity and Dissimilarity: A Medicinal Chemist’s View , 2002 .
[8] Thomas Scior,et al. Large compound databases for structure-activity relationships studies in drug discovery. , 2007, Mini reviews in medicinal chemistry.
[9] Wannian Zhang,et al. Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update , 2013, Medicinal research reviews.
[10] B. Fan,et al. Molecular similarity and diversity in chemoinformatics: From theory to applications , 2006, Molecular Diversity.
[11] Joshi Sd,et al. QSAR and 3D-QSAR in Drug Design Anti-Tubercular Drug DiscoveryStudies , 2016 .
[12] Patrick Bultinck,et al. Fast Calculation of Quantum Chemical Molecular Descriptors from the Electronegativity Equalization Method , 2003, J. Chem. Inf. Comput. Sci..
[13] Peter Willett,et al. Similarity searching using 2D structural fingerprints. , 2011, Methods in molecular biology.
[14] Tomasz Arodz,et al. Computational methods in developing quantitative structure-activity relationships (QSAR): a review. , 2006, Combinatorial chemistry & high throughput screening.
[15] Andy Vinter,et al. Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation , 2006, J. Chem. Inf. Model..
[16] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[17] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[18] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[19] M. Mezei,et al. Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.
[20] Malcolm J. McGregor,et al. Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design , 1999, J. Chem. Inf. Comput. Sci..
[21] Oleg Devinyak,et al. 3D-MoRSE descriptors explained. , 2014, Journal of molecular graphics & modelling.
[22] P. Schreiner,et al. Computational Chemistry: The Fate of Current Methods and Future Challenges. , 2018, Angewandte Chemie.
[23] D. Behrens,et al. Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium. , 1992, Cancer research.
[24] F. Bauss,et al. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] Grover,et al. Quantitative structure-property relationships in pharmaceutical research - Part 2. , 2000, Pharmaceutical science & technology today.
[26] S. Pickett,et al. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.
[27] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[28] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[29] D J Rogers,et al. A Computer Program for Classifying Plants. , 1960, Science.
[30] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[31] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[32] Nam Doo Kim,et al. Pharmacophore-based virtual screening: a review of recent applications , 2010, Expert opinion on drug discovery.
[33] Singh,et al. Quantitative structure-property relationships in pharmaceutical research - Part 1. , 2000, Pharmaceutical science & technology today.
[34] Patrick Bultinck,et al. The Electronegativity Equalization Method II: Applicability of Different Atomic Charge Schemes , 2002 .
[35] Joel S. Freundlich,et al. Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. , 2011, Trends in Microbiology.
[36] Subhash C Basak. Mathematical descriptors for the prediction of property, bioactivity, and toxicity of chemicals from their structure: a chemical-cum-biochemical approach. , 2013, Current computer-aided drug design.
[37] John M. Barnard,et al. Chemical Fragment Generation and Clustering Software , 1997, J. Chem. Inf. Comput. Sci..
[38] Klaus R. Liedl,et al. One Concept, Three Implementations of 3D Pharmacophore-Based Virtual Screening: Distinct Coverage of Chemical Search Space , 2010, J. Chem. Inf. Model..
[39] H. Kubinyi. QSAR and 3D QSAR in drug design Part 1: methodology , 1997 .
[40] John M. Barnard,et al. Clustering Methods and Their Uses in Computational Chemistry , 2003 .
[41] Yi Li,et al. Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for success. , 2003, Journal of molecular graphics & modelling.
[42] Sereina Riniker,et al. Open-source platform to benchmark fingerprints for ligand-based virtual screening , 2013, Journal of Cheminformatics.
[43] K. Baumann,et al. Chemoinformatic Classification Methods and their Applicability Domain , 2016, Molecular informatics.
[44] Péter Englert,et al. Efficient Heuristics for Maximum Common Substructure Search , 2015, J. Chem. Inf. Model..
[45] Malcolm J. McGregor,et al. Pharmacophore Fingerprinting. 2. Application to Primary Library Design , 2000, J. Chem. Inf. Comput. Sci..
[46] Harald Mauser,et al. Database Clustering with a Combination of Fingerprint and Maximum Common Substructure Methods , 2005, J. Chem. Inf. Model..
[47] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[48] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[49] J. Andrew Grant,et al. Small Molecule Shape-Fingerprints , 2005, J. Chem. Inf. Model..
[50] Qiang Zhang,et al. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.
[51] Adrià Cereto-Massagué,et al. Molecular fingerprint similarity search in virtual screening. , 2015, Methods.
[52] Oliver Koch,et al. What Can We Learn from Bioactivity Data? Chemoinformatics Tools and Applications in Chemical Biology Research. , 2017, ACS chemical biology.
[53] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[54] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[55] David M. Rocke,et al. Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.